Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Weisdorf

Showing results (1-10 of 389) with videos related to

Pageof 39
Sort By:
Hematology/Oncology and Stem Cell Therapy|June 23, 2017
Reduced-intensity versus myeloablative allogeneic transplantationDaniel J Weisdorf
Best Practice & Research. Clinical Haematology|December 7, 2010
How closely related is graft-vs-leukemia to donor/recipient disparity?Daniel J Weisdorf
Haematologica|July 10, 2012
Survival for older patients with acute myeloid leukemia: a population-based studyBetul Oran, Daniel J Weisdorf
Translational Research : the Journal of Laboratory and Clinical Medicine|April 11, 2020
Microbiota-based approaches to mitigate infectious complications of intensive chemotherapy in patients with acute leukemiaArmin Rashidi, Daniel J Weisdorf
Current Opinion in Hematology|September 14, 2011
Allogeneic stem cell transplantation in first complete remissionBetul Oran, Daniel J Weisdorf
Blood|October 14, 2017
Vorinostat is victorious in GVHD preventionShernan G Holtan, Daniel J Weisdorf
Current Opinion in Hematology|January 15, 2010
Reduced-intensity conditioning allogeneic stem cell transplantation for older adults: is it the standard of care?Brian L McClune, Daniel J Weisdorf
Blood|June 7, 2014
The donor's dilemmaShernan G Holtan, Daniel J Weisdorf
British Journal of Haematology|January 11, 2018
Treatment of relapsed/refractory acute myeloid leukaemia in adultsArmin Rashidi, Daniel J Weisdorf, Nelli Bejanyan
Oncotarget|November 16, 2017
UCB HCT in FLT3+ AMLCelalettin Ustun, Annalisa Ruggeri, Daniel J Weisdorf
Pageof 39

Showing results (1-10 of 389) with videos related to

Sort By:
Pageof 39
Hematology/Oncology and Stem Cell Therapy|June 23, 2017
Reduced-intensity versus myeloablative allogeneic transplantationDaniel J Weisdorf
Best Practice & Research. Clinical Haematology|December 7, 2010
How closely related is graft-vs-leukemia to donor/recipient disparity?Daniel J Weisdorf
Haematologica|July 10, 2012
Survival for older patients with acute myeloid leukemia: a population-based studyBetul Oran, Daniel J Weisdorf
Translational Research : the Journal of Laboratory and Clinical Medicine|April 11, 2020
Microbiota-based approaches to mitigate infectious complications of intensive chemotherapy in patients with acute leukemiaArmin Rashidi, Daniel J Weisdorf
Current Opinion in Hematology|September 14, 2011
Allogeneic stem cell transplantation in first complete remissionBetul Oran, Daniel J Weisdorf
Blood|October 14, 2017
Vorinostat is victorious in GVHD preventionShernan G Holtan, Daniel J Weisdorf
Current Opinion in Hematology|January 15, 2010
Reduced-intensity conditioning allogeneic stem cell transplantation for older adults: is it the standard of care?Brian L McClune, Daniel J Weisdorf
Blood|June 7, 2014
The donor's dilemmaShernan G Holtan, Daniel J Weisdorf
British Journal of Haematology|January 11, 2018
Treatment of relapsed/refractory acute myeloid leukaemia in adultsArmin Rashidi, Daniel J Weisdorf, Nelli Bejanyan
Oncotarget|November 16, 2017
UCB HCT in FLT3+ AMLCelalettin Ustun, Annalisa Ruggeri, Daniel J Weisdorf
Pageof 39